GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Alpha Healthcare Acquisition Corp III (NAS:ALPAW) » Definitions » Research & Development

Alpha Healthcare Acquisition III (Alpha Healthcare Acquisition III) Research & Development : $0.00 Mil (TTM As of Mar. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Alpha Healthcare Acquisition III Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Alpha Healthcare Acquisition III's Research & Development for the three months ended in Mar. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00 Mil.

Alpha Healthcare Acquisition III Research & Development Historical Data

The historical data trend for Alpha Healthcare Acquisition III's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Healthcare Acquisition III Research & Development Chart

Alpha Healthcare Acquisition III Annual Data
Trend Dec21 Dec22
Research & Development
- -

Alpha Healthcare Acquisition III Quarterly Data
Jan21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Research & Development Get a 7-Day Free Trial Premium Member Only - - - - -

Alpha Healthcare Acquisition III Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha Healthcare Acquisition III  (NAS:ALPAW) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Alpha Healthcare Acquisition III Research & Development Related Terms

Thank you for viewing the detailed overview of Alpha Healthcare Acquisition III's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpha Healthcare Acquisition III (Alpha Healthcare Acquisition III) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Alpha Healthcare Acquisition Corp III (NAS:ALPAW) » Definitions » Research & Development
Comparable Companies
BLNG OLIT NHIC ATAQ ABGI BNNR OCAX ROSE ARYD BLSA GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
1177 Avenue of the Americas, 5th Floor, New York, NY, USA, 10036
Website
Alpha Healthcare Acquisition Corp III is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.